Tuberculosis is an infectious disease of the lungs that's been with humanity for centuries and affects a quarter of the world's population. The stubborn disease killed over a million and a half people in 2021, mostly in lower- ...
Jan 18, 2023
0
48
A new analysis by Cedars-Sinai investigators is furthering the scientific community's understanding of COVID-19 immunity by showing that similar levels of COVID-19 antibodies are reached over an extended period of time in ...
Jan 10, 2023
0
39
Hepatitis B virus (HBV) infections remain a major global health problem—according to the World Health Organization there are around 300 million HBV carriers worldwide. Current treatments rarely succeed in curing the infection.
Jan 10, 2023
0
10
A team of researchers at FAU and Universitätsklinikum Erlangen has gained new insights into the maturation of SARS-CoV-specific antibodies after multiple vaccinations with the Comirnaty mRNA vaccine. They have now published ...
Jan 9, 2023
0
47
German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in Britain using the same mRNA technology, the company said on Friday.
Jan 6, 2023
0
40
The Pfizer-BioNTech and Moderna mRNA vaccines have played a large role in preventing deaths and severe infections from COVID-19. But researchers are still in the process of developing alternative approaches to vaccines to ...
Dec 15, 2022
0
9
Ebola epidemics occur periodically in various sub-Saharan African countries. While vaccines exist and have already received WHO Prequalification against the Zaire ebolavirus species, it is essential to pursue and intensify ...
Dec 14, 2022
0
37
COVID-19 vaccinations that combine two or more distinct variants of the SARS-CoV-2 virus could offer protection against both current and future "variants of concern," say scientists at the University of Cambridge and Medical ...
Dec 14, 2022
0
52
A nasal COVID-19 vaccine based on technology licensed from Washington University in St. Louis has been approved for emergency use in India as a booster for people who have already received two doses of other COVID-19 vaccines. ...
Dec 12, 2022
0
28
People infected with HIV who receive antiretroviral therapy form antibodies against SARS-CoV-2 after being vaccinated against COVID with mRNA vaccines. Their immune response to the vaccination is, however, less strong than ...
Dec 9, 2022
0
4
